Quick context
L-Carnitine
并非肽类。特定确诊缺乏症存在获批药物；这与一般健身宣称应区分。
Approved uses exist, but dose, formulation, device and monitoring are product- and indication-specific. A community table cannot replace the prescribing information or a prescription.
Back to all 64 profiles
Approved medicine特定用途获批
Community protocol · L-Carnitine
L-Carnitine: community information and evidence, clearly separated.
A complete substance profile covering documented community themes, scientific context and explicit safety boundaries. Missing or non-standardised data are not replaced with estimates.
Also known as: L Carnitine · Levocarnitine · Carnitine
Sources checked: 27 August 2026
重要安全与责任声明
本页记录并评估网络社区信息，不构成医疗或治疗建议、个体咨询，也不是使用邀请。
No medical, therapeutic or individual recommendation. Information is provided without warranty and used at your own risk. No liability for calculation errors, use, contamination, interactions or consequences.
Amounts, timing and cycles
Approved medicine
Approved uses exist, but dose, formulation, device and monitoring are product- and indication-specific. A community table cannot replace the prescribing information or a prescription.
Amount status
Only the prescribing information for the exact approved product applies; brands, concentrations and indications are not interchangeable.
Profile evidence level: established.
Timing
Intervals, time of day and missed-dose handling depend on the product and indication.
No individual recommendation.
Cycle/duration
Approved medicines are clinician-managed treatment, not freely designed community cycles.
No individual recommendation.
No matching detail page found in the reference source
The external page is used only to document community claims. Advertising and affiliate material were excluded; its content is neither approval nor proof of quality.
复配与 U-100 换算
No generic calculator
For approved finished products, only the relevant prescribing information, original concentration and intended delivery system apply. Prefilled pens, syringes or product-specific vials must not be converted with a generic U-100 table.
For approved finished products, only the relevant prescribing information, original concentration and intended delivery system apply. Prefilled pens, syringes or product-specific vials must not be converted with a generic U-100 table.
Mechanism and research questions
Amino-acid derivative transporting long-chain fatty acids into mitochondria
L-Carnitine is classified as “Amino-acid derivative transporting long-chain fatty acids into mitochondria”. 并非肽类。特定确诊缺乏症存在获批药物；这与一般健身宣称应区分。 This describes the investigated pathway but does not validate a community use, amount, route or combination.
脂肪酸转运
这项研究考察某些物质如何支持脂肪酸进出细胞的运输,类似于将脂肪运送到线粒体进行燃烧的快递服务。在实验室和动物模型中测量脂肪代谢标志物。
氧化还原辅因子生物学
这涉及在细胞能量和修复反应中充当辅助分子的物质,类似于支持多种不同化学反应的工具。在实验室中测量酶活性和细胞能量标志物。
维生素缺乏症替代
这项研究考察在确诊缺乏症时补充某种维生素,类似于补充身体真正需要却几乎耗尽的储备。临床研究中测量该维生素的血液水平及相关症状。
What communities discuss
These themes describe discussion and vendor claims. They do not prove benefit, safety, product identity or suitable use.
体重管理论坛
在这些论坛中,用户比较不同产品之间自己的体重变化、副作用以及感知到的食欲变化。经常会分享前后对比照片和个人时间线。这类轶事和商家营销宣传并不是科学的疗效证明。
综合健康论坛
人们在此交流使用各类产品后情绪、睡眠和整体感受等更宽泛的健康印象,通常没有结构化的记录。这类笼统印象无法替代有针对性的临床检查。
精力与疲劳轶事
人们报告在使用线粒体肽或维生素注射后主观感受到的精力提升,通常基于个人每日精力评分。这类印象极易受安慰剂效应影响。
Adverse effects and risk boundaries
- 风险尤其取决于实际成分、剂型、浓度、辅料及医学理由。维生素、辅因子和稀释剂同样可能产生不良反应或相互作用。
- Local reaction, infection, abscess and contamination are possible with any injection that is not professionally manufactured and administered.
- A label or clear appearance does not exclude unknown purity, wrong identity, endotoxins or concentration errors.
Exclusion groups and professional assessment
- 过敏、肝肾疾病、妊娠、相关药物，以及缺乏诊断或产品身份信息，均须在使用前澄清。
- Acute symptoms, allergic reaction, breathing difficulty, chest pain, neurological deficits or severe abdominal pain require immediate medical care.
- Children and adolescents, pregnancy/breastfeeding, and people with relevant disease should not be part of unsupervised experiments.
Monitoring and laboratory markers
- 监测应服从具体医学目的，例如确认缺乏、器官功能或耐受性。笼统的肽类化验组合没有意义。
- Baseline, objective, measurement timing and stop criteria must be defined professionally in advance. Individual laboratory values cannot compensate for unknown product quality.
Evidence boundary
证据充分
一般健身方面的说法应与已获批的缺乏症适应症区分开来。
Published evidence
所述生物学作用已有充分依据,或针对明确产品和用途已有经监管机构审查的大量人体数据。这些结论不能自动套用于其他产品或用途。
左旋肉碱不是肽类物质,而是一种氨基酸衍生物,具有严格限定的已获批缺乏症适应症。
Storage and stability
- The manufacturer label and prescribing information take priority. Storage instructions from a different product do not transfer.
- Unapproved vials often lack dependable stability data before and after mixing; ‘2–8 °C’ or ‘28 days’ is not a universal standard.
- Do not use after seal damage, particles, cloudiness, discoloration, unknown date or interrupted cold chain. Visual inspection does not prove sterility.
Troubleshooting and error sources
- U-100 units measure volume, not drug amount: 100 U equals 1 mL. A wrong concentration makes every unit figure wrong.
- Do not shake or dilute further to ‘fix’ cloudiness, particles or uncertain solubility; discard and obtain professional clarification.
- Do not calculate a double or extra amount to compensate for missed use or an uncertain injection.
- Without a COA, clear supplier, correct label and consistent vial information, identity is not confirmed.
Regulatory status and WADA
特定用途获批
在至少一个司法辖区作为特定适应证的处方活性成分；本网站不提供该产品。
WADA 2026
The atlas has no explicit WADA flag for this profile. That does not automatically mean every form, route or related class is permitted in sport.
WADA — 2026 Prohibited ListComparisons and related profiles
Combinations / stacks
- Combinations change effects, adverse effects and laboratory values; evidence for one substance does not establish the safety of a stack.
- Overlapping pathways may add up. Hormonal, glucose, blood-pressure, coagulation, immune and sedating effects are important potential interactions.
- Non-standardised blends prevent separate dosing, cause attribution and dependable reconstitution.
Frequently asked questions
Is an amount shown here a recommendation?
No. This page separates approved product information, study protocols and community information. No number or calculator is an individual dosing recommendation.
Does the U-100 calculator prove correct use?
No. It only converts mass, volume and syringe scale. It cannot check identity, purity, sterility, stability, solvent or medical suitability.
Can this profile be combined with other substances?
Safety of a combination cannot be inferred from a single-substance profile. Overlapping pathways, medicines and undefined blends can increase risk.
Which source controls when information conflicts?
For approved medicines, the current prescribing information and treating professional control. For research substances, conflict shows that no dependable self-use standard exists.
Are community claims clinical evidence?
No. Anecdotes can generate questions but do not replace controlled studies, regulatory review, or identity and quality testing.
Sources and evidence layers
Primary sources and official registries take priority. The community reference is labelled separately.
- Primary/technical sourceNIH: carnitine fact sheet
- Primary/technical sourceFDA: official drug-label search
- Primary/technical sourceDailyMed — Levocarnitine injection prescribing information